218696
Casein Kinase I Inhibitor, D4476
CK1 Inhibitor, 4-(4-(2,3-Dihydrobenzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide
Skontaktuj się z Zespołem Obsługi Klienta jeśli masz jakieś pytania:
Merck Sp. z o.o.
ul. Jutrzenki 137
02-231 Warszawa
Polska
Telefon: 022 53 59 770
Faks: 022 53 59 945
E-mail: dzial.handlowy@merckgroup.com
18 maj 2013
ładowanie
A cell-permeable triaryl substituted imidazolo compound that acts as a potent, reversible and relatively specific ATP-competitive inhibitor of CK1 (IC50 = 0.2 µM from S. pombe; 0.3 µM for CK1δ) and ALK5 (IC50 = 0.5 µM). A weak inhibitor of p38α MAP kinase (IC50 = 12 µM) and only weakly affects the activities of a panel of kinases tested, including PKB, SGK and GSK-3β. Suppresses the site-specific phosphorylation (Ser322 and Ser325) and nuclear exclusion of FOXO1a in H4IIE hepatoma cells. Shown to be ~10-fold more potent than IC261 (Cat. No. 400090; IC50 = 2.5 µM for CK1).
| Informacje o produkcie | |||
|---|---|---|---|
| Formularz | Crystalline solid | ||
| Primary Target | CK1, CK1d | ||
| Primary Target IC50 | 0.2 µM, 0.3 µM | ||
| Secondary target | ALK5 (IC50 = 0.5 µM), p38a MAP kinase (IC50 = 12 µM) | ||
| Masa molowa | 398.4 | ||
| Protect from Light | Tak | ||
| Zapakowano w atmosferze gazu obojętnego | Tak | ||
| Cell permeable | Tak | ||
| ATP Competitive | Tak | ||
| Purity | ≥95% by HPLC | ||
| Rozpuszczalność w wodzie | DMSO | ||
| Wzór chemiczny | C23H18N4O3 | ||
| Numer CAS | 301836-43-1 | ||
| Informacje nt. magazynowania i transportu | |||
|---|---|---|---|
| Składowanie | +2°C to +8°C | ||
| Wysyłka |
Ambient Temperature Only
Standard Handling |
||
